Melanotan II test results: how often vials pass lab testing
Melanotan II was never approved, and more than a third of recent samples failed lab testing. Here are the numbers and how they compare with PT-141, the approved drug that came out of it.
Of the last 177 Melanotan II (melanotan 2) samples with a result in Finnrick's public lab-testing database, 110 passed and 67 failed: 62 percent of Melanotan II test results were a pass. Another 7 came back incomplete and are left out. Finnrick has published 184 Melanotan II tests from 46 sellers since 19 Feb 2025.
Melanotan II is a synthetic, non-selective melanocortin agonist first researched as a way to tan without sun exposure. It was never approved, and its side-effect profile, including a real mole and skin-monitoring caveat, is part of why. PT-141, a more focused compound spun off from it, became an approved drug.
The short version
- 62 percent of recent samples passed. 110 passed and 67 failed, of the last 177 with a result.
- It is not FDA-approved and never has been. FDA plans to take it to its compounding committee before the end of February 2027.
- A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
- We do not name sellers. The numbers describe the market, not any one shop.
Melanotan II test results in numbers
| Measure | Melanotan II |
|---|---|
| Published tests | 184 |
| Sellers with at least one test | 46 |
| First and latest test | 19 Feb 2025 to 29 Oct 2026 |
| Recent results counted | 177 (7 incomplete left out) |
| Passed | 110 |
| Failed | 67 |
| Pass rate | 62% |
| Rank by pass rate | 6 of 14 on our peptide test results page |
Figures from Finnrick's public Melanotan II page, checked on 12 November 2026. They will change as new results come in.
What counts as a pass or a fail
These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.
The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.
Is melanotan II FDA-approved?
No (see our melanotan II page). FDA took it out of Category 2 in April 2026 after its nominators withdrew, while citing case reports of "serious adverse events including melanoma, posterior reversible encephalopathy syndrome". Leaving Category 2 does not make it compoundable, and FDA has said it will consult its compounding committee before the end of February 2027 (FDA Category 2 peptides).
More than a third failed, beside its approved offspring
Of the last 177 melanotan II samples with a result, 67 failed and 110 passed. PT-141, the compound developed from it, passed 65 percent of its research samples (PT-141 test results). Finnrick has published 184 melanotan II tests from 46 sellers since 19 Feb 2025.
A clean result on a vial does not answer the safety question FDA raised. It only tells you what was in that vial.
Before you buy Melanotan II
There is no approved melanotan II product and no pharmacy route for it. A prescription is not an option today.
Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.
Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.
Questions people ask
What percentage of Melanotan II fails lab testing?
In Finnrick's public test database, 67 of the last 177 Melanotan II samples with a result failed, which is 38 percent, and 110 passed. Tests that came back incomplete are left out.
Is Melanotan II FDA-approved?
It is not FDA-approved and never has been. FDA plans to take it to its compounding committee before the end of February 2027.
Does a passing lab test mean Melanotan II is safe?
No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Melanotan II is safe or does anything in people.
Is melanotan II the same as PT-141?
No. PT-141 (bremelanotide) was developed from melanotan II as a more selective compound and is approved as Vyleesi for one use. Melanotan II itself was never approved.
Sources
- Methodology, Finnrick, accessed 12 November 2026
- Melanotan II product page and public test history, Finnrick, accessed 12 November 2026
